Beijing Airdoc Technology Co. Ltd. Class H (HK:2251) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Beijing Airdoc Technology Co., Ltd. is proposing a change in the allocation of the unutilized HK$723.7 million from its Global Offering proceeds, to be discussed in the 2024 first extraordinary general meeting. About 51.6% of the proceeds from the Global Offering have been utilized as of June 30, 2024, with the remainder set for reallocation according to the company’s updated R&D progress, operation levels, and business strategies. The funds are earmarked for further development and commercialization of its core products, with full utilization expected by 2026.
For further insights into HK:2251 stock, check out TipRanks’ Stock Analysis page.